Drug Discovery - 2009 Schedule

Last Updated on Thursday, 03 September 2009 15:04 Written by Jackie Howard Wednesday, 11 February 2009 16:53

drugdiscoverybanner

Main Sponsor:

KEYNOTE SPEAKERS:

Neil Weir, UCB

'The increasing role for automated systems in drug discovery'

Dave Tapolczay, MRC-Technology

"The Future of Drug Discovery Research in the UK and beyond and the potential for academic partnerships"

Ted Bianco, Wellcome Trust

"Fostering drug discovery through dedicated funding mechanisms: a Wellcome Trust perspective"

A PDF copy of the provisional timetable is now available (click to download) (updated 07/08/09)

NOTE: PROVISIONAL SPEAKER TIMINGS ARE PROVISIONAL AND SUBJECT TO CHANGE AT THIS TIME.

DAY 1 - MONDAY 7TH SEPTEMBER 09

Programme
Monday 7th September 09	8.00 am 9.15am - 9.30am	Registration Introduction and Welcome Adrian Kinkaid and Steve Rees
	9.30am - 10.15am	Keynote Presentation Neil Weir, UCB
	10.15am - 10.45am	COFFEE BREAK

	Drug Discovery for GPCR Targets	Structural Biology and Rational Drug Discovery	Assay Development and Screening	ELRIG Robotics Workshop
SPONSORS
Session Chairs 10.45 - 11.00	Fiona Marshall, Heptares Annette Gilchrist, Northwestern Uni	Steve Garland, GSK Ray Owens, MRC OPPF	David Cronk, BioFocus Stephen Hill, Nottingham Uni.	Eric Tang, AZ Malcolm Crook, PAA
11..00 – 11.30	'GPCR Assays for Ultra High Throughput Screening' Priya Kunapuli, Merck	Structure-Based Drug Discovery in Epigenetics: The Writers, Readers and Erasers, of Histone Methylation' Wyatt Yue, SGC	'Primary cells and HTS: the good, the bad and the ugly' Richard Eglen, PerkinElmer	'Application of Mass Production Design and Manufacturing Principles to HT Lab Automation' James Mainquist, GNF
11.30 - 12.00	'The crystal structure of the adenosine A_2A receptor. Implications for GPCR drug design' Ad Ijzerman, Leiden Uni	'DrugFinder: Harnessing modern web technologies for virtual screening' Paul Finn, InhibOx	'Lead Discovery for the HMTome' Margaret Porter Scott, Epizyme	'Use of Computer Simulation to optimize the output of Lab Automation' Mike Allen, LeanSigmaLab
12.00 - 12.30	'Engineering stabilised GPCRs for drug discovery and screening' Fiona Marshall, Heptares Therapeutics	'Exploiting structure and property based design in the discovery of orally active anticoagulants' Rob Young, GSK	'Automated Patch Clamp Electrophysiology: Emerging Tools for Ion Channel Screening' Alison Haythornthwaite, Nanion	'Impact of Modular Automation Systems in a Lab Environment' Jon Wingfield, AstraZeneca
12.30 - 1.00	'Allosteric Modulators of Family C GPCRs' Brice Campo, Addex Pharma	Snapshots: Proteros, Rigaku	Snapshots: Essen, Bellbrook Cisbio, MDS, Corning, TTP Labtech	'A Common Goal: Automation in Academia and Pharma-Biotech' Sheraz Gul, European Screening Port
1.00 - 2.30	LUNCH			2.15 - 2.45 'Standardisation of Robotic interfaces-SiLa initiative' Jason Meredith, Tecan
2.30 - 3.00	'Allosteric Regulation of Ligand Binding To Monomeric GPCRs By G Proteins' Roger Sunahara, Michigan Uni	'Structural screening of fragments for drug discovery' Phil Day, Astex	'Designing Assays that Fulfil Therapeutic Areas needs:a Change in Strategy and the Application of Design of Experiments (DOE) in Plate Based Assay Development' Rachel Russell, Pfizer	2.45 - 3.15 'Autonomous Experimentation: Coupling Machine Learning withComputer Controlled Microfluidics' Chris Lovell, Southampton Uni.
3.00 - 3.30	'Pioneering a New Class of Drugs' Stephen Hunt III, Ascent Therapuetics	'Fragment hit finding and optimisation in early drug discovery' John Barker, Evotec	*'Allosteric Modulation of the TrkB receptor* : *The discovery of active, non-peptide, small molecules against a previously intractable target'* Greg Osborne, GSK	3.15 - 3.45 ‘Robot Scientists' Andrew Sparkes, Aberyswyth University
3.30 - 4.15	COFFEE
4.15 - 4.45	'GPCR-HIT - Enabling GPCR heteromer-based drug discovery' Kevin Pfleger, Dimerix	'Cysteine proteases from RNA viruses and protozoa:Structure-assisted discovery of new anti-infectives' Prof. Rolf Hilgenfeld, Lubeck University.	'Impact of New Assay Technology on Challenging Drug Targets' Jon Ellery, Takeda	Swarm Robotics: Advantages and Challenges Serge Kernbach, Stuttgart University
4.45 - 5.15	'New approaches to the discovery of allosteric modulators of GPCRs' Stephan Schann, Domain Therapeutics	'Aeropath: An EU Consortium for Characterization and Exploitation of Novel Gram-Negative Drug Prof. Bill Hunter, Dundee Uni.	'Kinetics of Ligand Binding at the Single Cell Level' Lauren May, Nottingham Uni	'Medical Nanorobotics for enhanced target drug delivery through the human vascular network' Prof. Sylvain Martel, Montreal
5.15 - 7.30	DRINKS RECEPTION	Beer Serving Robots Robotic Demonstrations	Bottisham School Winning Robot Team	Beatles Tribute Band - Sponsored by The Automation Partnership